This is potentially indicative of an irregular circadian rhythm being established in ME/CFS patients vs. healthy controls, especially with the hypo-methylated ryanodine receptor RYR1 having an important role setting the clock to the evening phase in response to light [46]. The gene discussed is RYR1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.